Xiaomi is set to report its 2Q25 earnings later this month. We expect robust revenue growth supported by the IoT, EV and internet services segments. However, margins are projected to fall sequentially, mainly due to rising DDR4 prices for the smartphone business and a shift in the IoT product mix. Overall, we expect adjusted net profit to grow 71.4% yoy to Rmb10.3b. Maintain BUY; trim target price slightly to HK$69.20.
KEY HIGHLIGHTS Results BeOne Medicines (6160 HK/BUY/HK$182.70/Target: HK$240.00) BeOne Medicines’ 1H25 revenue surged by 44.7% yoy to US$2.4b and adjusted net earnings amounted to US$389m, beating consensus estimates. Management raised revenue and gross margin guidance in 2025. We believe BRUKINSA's strong sales outlook and improving operational efficiency bode well for robust earnings and free cash flow expansion. Its R&D efforts will also support sustainable long-term growth through new prod...
This report provides the latest update on the US EV Charging Infrastructure. It contains information - about number of charging stations, number of charging ports, state-level information on EV Charging infrastructure as well as information on which company currently has the largest network of EV charging stations/ports in the United States.
Two Directors at Palo Alto Networks Inc sold after exercising options/sold 220,774 shares at between 171.582USD and 172.805USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades ...
In July, the HSI and MSCI China index extended their growths, rising 2.9% mom and 4.5% mom respectively to reach their peak on 24 July before pulling pack in the latest week, as investors tend to take profit after the Politburo announcement. With another 90-day tariff delay from the US, we maintain a positive outlook for leading domestic stocks in healthcare and IT. New additions to our BUY list are JBM Healthcare and Lenovo. We take profit on CATL, Han’s Laser, KE Holdings and Longfor.
Moody's Ratings (Moody's) affirmed the Baa3 long-term issuer rating of Tesla, Inc. (Tesla). The outlook remains stable. The affirmation reflects our expectation that Tesla's vehicle technology, software and AI competencies provide a platform for continuing innovation and new product offerings. The...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.